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Abstract
Background
Malaria transmission is highly heterogeneous, generating malaria hotspots that can fuel
malaria transmission across a wider area. Targeting hotspots may represent an efficacious
strategy for reducing malaria transmission. We determined the impact of interventions tar-
geted to serologically defined malaria hotspots on malaria transmission both inside hotspots
and in surrounding communities.
Methods and Findings
Twenty-seven serologically defined malaria hotspots were detected in a survey conducted
from 24 June to 31 July 2011 that included 17,503 individuals from 3,213 compounds in a
100-km2 area in Rachuonyo South District, Kenya. In a cluster-randomized trial from 22
March to 15 April 2012, we randomly allocated five clusters to hotspot-targeted interven-
tions with larviciding, distribution of long-lasting insecticide-treated nets, indoor residual
spraying, and focal mass drug administration (2,082 individuals in 432 compounds); five
control clusters received malaria control following Kenyan national policy (2,468 individuals
in 512 compounds). Our primary outcome measure was parasite prevalence in evaluation
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zones up to 500 m outside hotspots, determined by nested PCR (nPCR) at baseline and 8
wk (16 June–6 July 2012) and 16 wk (21 August–10 September 2012) post-intervention by
technicians blinded to the intervention arm. Secondary outcome measures were parasite
prevalence inside hotpots, parasite prevalence in the evaluation zone as a function of dis-
tance from the hotspot boundary, Anophelesmosquito density, mosquito breeding site pro-
ductivity, malaria incidence by passive case detection, and the safety and acceptability of
the interventions. Intervention coverage exceeded 87% for all interventions. Hotspot-tar-
geted interventions did not result in a change in nPCR parasite prevalence outside hotspot
boundaries (p 0.187). We observed an average reduction in nPCR parasite prevalence of
10.2% (95% CI −1.3 to 21.7%) inside hotspots 8 wk post-intervention that was statistically
significant after adjustment for covariates (p = 0.024), but not 16 wk post-intervention (p =
0.265). We observed no statistically significant trend in the effect of the intervention on
nPCR parasite prevalence in the evaluation zone in relation to distance from the hotspot
boundary 8 wk (p = 0.27) or 16 wk post-intervention (p = 0.75). Thirty-six patients with clini-
cal malaria confirmed by rapid diagnostic test could be located to intervention or control
clusters, with no apparent difference between the study arms. In intervention clusters we
caught an average of 1.14 female anophelines inside hotspots and 0.47 in evaluation
zones; in control clusters we caught an average of 0.90 female anophelines inside hotspots
and 0.50 in evaluation zones, with no apparent difference between study arms. Our trial
was not powered to detect subtle effects of hotspot-targeted interventions nor designed to
detect effects of interventions over multiple transmission seasons.
Conclusions
Despite high coverage, the impact of interventions targeting malaria vectors and human
infections on nPCR parasite prevalence was modest, transient, and restricted to the tar-
geted hotspot areas. Our findings suggest that transmission may not primarily occur from
hotspots to the surrounding areas and that areas with highly heterogeneous but widespread
malaria transmission may currently benefit most from an untargeted community-wide
approach. Hotspot-targeted approaches may have more validity in settings where human
settlement is more nuclear.
Trial registration
ClinicalTrials.gov NCT01575613
Introduction
The transmission of many infectious agents, including malaria, is highly heterogeneous in
space and time. In the last decade, considerable efforts have been made to better estimate the
global and local burden of malaria. At a micro-epidemiological scale in endemic areas, numer-
ous factors influence malaria transmission dynamics, including distance to the nearest mos-
quito breeding site [1–4], wind direction [5], vegetation [6], house construction features
[1,3,4], and human genetic [2,3,7] and behavioral factors [1–3,8]. Variations in these factors
over a small area can result in spatially heterogeneous transmission and can result in malaria
hotspots, where transmission intensity is higher than in the surrounding areas. These malaria
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hotspots may be present in all malaria endemic areas but are most readily identifiable in areas
of low transmission intensity, where malaria incidence, parasite prevalence, and mosquito
exposure may be elevated inside hotspots [5,6,9].
Malaria control efforts targeted to transmission hotspots may have benefits for both the tar-
geted area and the wider community. Mosquito densities are highest in hotspots, and individu-
als in hotspots may amplify transmission by transmitting malaria parasites to a large number
of mosquitoes that fuel transmission to wider areas. This amplified transmission can lead to
1.5- to 4-fold increases in the basic reproductive number of malaria parasites [9–11]. Successful
targeting of malaria control efforts to hotspots may therefore be a highly efficient method to
reduce malaria transmission in a wider area and achieve community protection by eliminating
transmission in a relatively small geographical area [9,11,12]. Such targeted interventions are
likely to become increasingly important tools in malaria elimination efforts once transmission
in an area has decreased but is maintained in hotspots of malaria transmission [13]. We
hypothesized that combined malaria control interventions targeted at hotspots could reduce
malaria transmission not only inside these hotspots but also in adjacent areas. To test this, we
identified hotspots of malaria transmission in a low endemic area in the western Kenyan high-
lands, and conducted a cluster-randomized controlled trial to measure the effect of hotspot-tar-
geted interventions in evaluation zones surrounding malaria hotspots.
Methods
The original protocol for the cluster-randomized trial (S1 Text) and the supporting CONSORT
checklist (S2 Text) are provided. A detailed study protocol was previously published [14].
Ethics Statement
This study was approved by the ethical committees of the London School of Hygiene & Tropi-
cal Medicine (LSHTM 5721) and the Kenya Medical Research Institute (KEMRI) (SSC 1802/
2163/2495). Consenting procedures are described in detail elsewhere [14]. Prior to the commu-
nity survey (2011) and randomization for the cluster-randomized trial (2012), community sen-
sitization meetings were organized. Informed written consent was sought from all individuals
participating in surveys or, where appropriate, their parents or guardians. Written assent was
obtained from all children aged 13–17 y, accompanied by a consent form signed by the parent
or guardian. Prior to indoor residual spraying (IRS) and the distribution of long-lasting insecti-
cide-treated nets (LLINs), written informed consent was obtained from the head of compound.
Prior to focal mass drug administration (MDA), individual written consent and/or assent was
obtained. Larviciding commenced after written approval from the Division of Malaria Control
and Kenyan Pest Control Products Board and with the oral approval of the district administra-
tion, fisheries, and persons responsible for any privately owned permanent water bodies such
as fishponds.
Study Area and Population
A 5 × 20 km study area located at 1,400 m to 1,650 m above sea level was selected in Rachuonyo
South District, western Kenya (34.75–34.94E, 0.41–0.53S) and divided into 500 × 500 m cells
(Fig 1). Compounds in the study area are distributed broadly across a rolling landscape inter-
sected by streams and rivers; compounds typically comprised a median of two houses (inter-
quartile range [IQR] 1 to 3) and 5 inhabitants (IQR 3 to 7). Malaria transmission in the area is
seasonal and associated with seasonal rains that typically peak between March and June and
between October and November. Transmission intensity in the study area is generally low;
mean parasite prevalence in community surveys in 2010 by rapid diagnostic test (RDT) was
Hotspot-Targeted Interventions and Malaria Transmission
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10%, with marked spatial heterogeneity [14,15]. The principal malaria vectors are Anopheles
gambiae s.s., A. arabiensis, and A. funestus [16]. The Ministry of Public Health and Sanitation
Fig 1. The study area in the highlands of western Kenya. The study area comprised a 5 × 20 km rectangle in Rachuonyo South District, Nyanza Province.
doi:10.1371/journal.pmed.1001993.g001
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has been involved in the distribution of insecticide-treated nets (ITNs) in the area for many
years; ITN ownership in children below 5 y of age was 82.7% in 2010 [15]. Since 2009, the Divi-
sion of Malaria Control has carried out annual IRS campaigns with pyrethroids in structures
that serve as sleeping spaces, reaching70% of all compounds [14].
Study Design
Community survey and hotspot detection. The procedures for hotspot detection and the
cluster-randomized trial are described in detail elsewhere [14]. We imported geo-location data
for all structures in the study area, collected from high-resolution satellite data (QuickBird;
DigitalGlobe) into a geographical information system (ArcGIS 9.2; Esri). Manually digitizing
structures yielded 8,632 structures, with a median of 45 structures (IQR 35–52) per 500 × 500
m cell. For hotspot identification, we carried out a community survey in 2011 to obtain mea-
surements from50 individuals per cell, sampling in equal ratios from predefined age strata
(5 y, 6–10 y, 11–15 y, 16–25 y and>25 y). Twenty field teams consisting of one enumerator,
one field worker, and one person trained for blood sample collection were equipped with high-
resolution maps and a handheld GPS receiver (GPSMAP 62s; Garmin International) with pre-
loaded waypoints for 16 randomly selected compounds and cell boundaries. Compounds were
eligible for sampling if at least one adult and one child (<15 y) were permanent residents
(defined as sleeping regularly in the structure) and written informed consent was obtained. If a
selected compound did not satisfy these criteria, the nearest non-selected inhabited compound
was selected as a replacement. Participating individuals in the community survey were
screened by axillary thermometer for fever, and those with fever were tested by RDT (HRP-2,
Paracheck, Orchid Biomedical Systems) for on-site malaria diagnosis and treatment with arte-
mether-lumefantrine (AL) (Coartem, Novartis) if RDT positive. Febrile individuals who were
RDT negative, pregnant, or below 6 mo of age were accompanied to a local health facility for a
full clinical assessment and treatment.
Finger prick blood was collected from all participants on filter paper (3MMWhatman). Fil-
ter papers were stored with desiccant at −20°C until used to detect antibodies against Plasmo-
dium falciparum apical membrane antigen-1 (AMA-1) and merozoite surface protein-1 (MSP-
119) using established ELISA methodologies [17,18] and to detect parasite prevalence by nested
PCR (nPCR) targeting the 18S rRNA gene [18]. All molecular and serological assays for the
2011 community survey were conducted at the KEMRI/Centers for Disease Control and Pre-
vention (CDC) laboratories in Kisumu, Kenya. Because of the labor intensiveness and resource
intensiveness of DNA extraction and nPCR and the necessity of obtaining results on nPCR
parasite prevalence prior to hotspot selection, nPCR was only performed on only a random
selection of samples (12,912/16,381). Data on demography, travel behavior, sleeping times, his-
tory of malaria treatment, and use of protective measures were collected on a personal digital
assistant (HP Ipaq 210, Windows Mobile 6.1) with a precoded questionnaire programmed in
Visual Basic (Visual CE v11.0).
Spatial scanning for hotspot detection. Using data from this community survey, we
screened for local clustering of seroreactivity using SaTScan software [19]. Spatial scans were
based on the prevalence of antibodies to either AMA-1 or MSP-119 (Bernoulli model) and
log10-transformed optical density values for AMA-1 and MSP-119, where the highest age-
adjusted optical density value for either antigen was used in a normal probability model. Circu-
lar and elliptic windows were used to systematically scan segments of the study area using a
2 × 4 km rolling window, allowing for a hotspot size with<1 km radius and<25% of the popu-
lation of each window scanned. This rolling window was chosen since malaria transmission
was expected to show considerable variation with altitude, as well as micro-epidemiological
Hotspot-Targeted Interventions and Malaria Transmission
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variation within altitude bands. We thus scanned sections of the study area for variations in
antibody prevalence and density compared to local average values. A hotspot was defined as an
area for which there was strong evidence (p< 0.05) that the observed prevalence and density
of combined AMA-1 and MSP-119 antibodies were higher than expected as calculated from the
prevalence within the rolling window [14]. nPCR data were not used for screening for local
clustering or hotspot detection but were used to detect current infections in serologically
defined hotspots and thereby confirm ongoing malaria transmission in these localities.
Cluster-Randomized Trial on the Effect of Hotspot-Targeted
Interventions
Sample size. In the absence of published studies that quantified the impact of hotspot-tar-
geted interventions, we estimated the predicted impact of our interventions using an individ-
ual-based simulation model [20]. Simulations of hotspot-targeted LLIN distribution and IRS
implementation indicated the possible interruption of transmission, both inside and outside
malaria hotspots, reducing overall parasite prevalence to<5%, in a manner that is apparent in
the first season and sustainable in the following years [14]. A previous study on the community
benefits of ITNs indicated that the indirect beneficial effect on malaria transmission is most
pronounced within 500 m of the intervention area [21]. We used these findings to design our
trial and define evaluation zones that were dichotomized into two categories based on distance
from the hotspot boundary (1–249 m and 250–500 m). Assuming a sample of 200 randomly
selected individuals in the evaluation zone of each cluster, a coefficient of variation of true pro-
portions between clusters within each group (k) of 0.4, and a mean nPCR parasite prevalence
of 15% and 5% in the control and intervention clusters, respectively, the study would require
five clusters per study arm for 80% power at the 5% significance level.
Randomization. Clusters were serologically defined hotspots with a surrounding 500-m
evaluation zone. Hotspots were eligible for the intervention trial if no other hotspots were
detected within 1.0 km of the border of the evaluation zone. Ten selected clusters were allocated
to the intervention or control arm by a trial statistician using computer-generated random
tables.
Intervention. In the intervention arm, four interventions were concurrently rolled out
inside hotspots, starting in March 2012 before the long rainy season. (i) All stagnant water bod-
ies (permanent and temporary) were treated on a weekly basis with water-dispersible granule
formulations of the commercial strains of Bacillus thuringiensis var. israelensis (VectoBac W,
Valent BioSciences) [22] by a team that was permanently present in the hotspot with one
supervisor per cluster. Larviciding continued fromMarch to August 2012. (ii) One LLIN (Per-
maNet W 3.0; Vestergaard Frandsen) was provided for every two compound members by a
team of two field workers per cluster. Leaflets with instructions in the local dialect and verbal
explanations about correct usage were provided. The use of LLINs was confirmed in a follow-
up visit 6 to 8 wk after initial distribution during which the presence and quality of study
LLINs were observed and replacement LLINs issued if required. Any adverse events following
net use were recorded by the study team during the LLIN follow-up visit and care given as
needed. (iii) IRS with the pyrethroid insecticide lambda-cyhalothrin (ICON, Syngenta) was
performed by district teams in all eligible compound structures, supervised by two study staff
per intervention cluster. Sensitization visits were undertaken prior to the visits of IRS teams to
maximize the presence of at least one compound member on the days of spraying, to maximize
compound participation. Adverse events associated with the insecticides used in intervention
compounds were reported to the study team during the LLIN follow-up visit and care given as
needed. (iv) All compounds were visited to determine whether they were eligible for focal
Hotspot-Targeted Interventions and Malaria Transmission
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MDA as described in detail elsewhere [23]; MDA was implemented by seven teams that each
consisted of two fieldworkers, one local guide, and one supervisor who was shared between two
teams. A sentinel population of all febrile individuals (tympanic temperature> 37.5°C) and all
individuals aged 6 mo–15 y was screened for malaria infection by RDT (HRP-2- and pLDH-
based First Response W, Premier Medical Corporation). If one or more compound members
were RDT positive, all compound members received a curative dose of AL [14]. Half of the
doses (doses 1, 3, and 5, from a total of six) were directly observed and given with fatty food
(>1.5 g fat); the other doses were taken without supervision. AL blister packs were collected for
adherence monitoring. We used three measures of coverage for MDA: the proportion of com-
pounds participating in screening of the sentinel population, the proportion of compounds eli-
gible for MDA based on1 RDT-positive inhabitant, and the proportion of inhabitants of
eligible compounds who received all six doses of AL. Adverse effects monitoring was conducted
in conjunction with the daily drug supervision visits. Any symptoms reported on the final day
of treatment were recorded and followed up clinically.
Control clusters and evaluation zones received malaria control following Kenyan national
policy: annual IRS (ICON, lambda-cyhalothrin), which began in late April 2012 and was com-
pleted in June/July 2012, routine case management at health facilities (i.e., all suspected cases of
malaria were treated with AL after confirmation of infection by microscopy or RDT), and dis-
tribution of LLINs at antenatal clinics. No community distribution of LLINs was carried out in
control clusters during the study period.
Primary and secondary outcome measures. The primary outcome measure was parasite
prevalence in the evaluation zone surrounding malaria hotspots, measured by nPCR. Second-
ary outcome measures were (i) parasite prevalence inside hotspots, (ii) parasite prevalence in
the evaluation zone as a function of distance from the hotspot boundary, (iii) Anophelesmos-
quito density, (iv) mosquito breeding site productivity, (v) the number of malaria cases
reported at health facilities by passive case detection (PCD), and (vi) the safety and acceptabil-
ity of the interventions. As an exploratory endpoint, we determined the number of P. falcipa-
rum clones (complexity of malaria infections) inside and outside targeted hotspots.
Follow-up. Cross-sectional surveys were conducted in 22 March–15 April 2012 prior to
the intervention (baseline) and then at 8 wk (16 June–6 July, corresponding to the peak of the
rainy season) and 16 wk (21 August–10 September, corresponding to the end of the rainy sea-
son) after the intervention. In each survey, 25 compounds each were randomly selected from
the following settings: (i) inside hotspots, (ii) 1–249 m from the hotspot boundary, and (iii)
250–500 m from the hotspot boundary. All occupants in selected compounds older than 6 mo
of age were sampled. Follow-up surveys were conducted by a total of 15 teams that each com-
prised two fieldworkers, one local guide, and one supervisor who was shared between two
teams. Teams were equipped with high-resolution maps and GPS receivers with preloaded
waypoints, as described above. In intervention hotspots, data were available for all compounds
at baseline and were therefore included in the analysis.
Laboratory methods. All finger prick blood samples collected at baseline (n = 3,808) and
8 wk (n = 3,817) and 16 wk after the intervention (n = 3,955) were tested for P. falciparum
parasitemia by nPCR targeting the 18S rRNA gene [18]. All nPCR-positive samples were tested
for the presence of multiple allelic forms using the polymorphic merozoite surface protein-2
gene [24].
Passive Surveillance for Clinical Malaria Incidence
All study participants from intervention and control clusters (hotspots and surrounding evalu-
ation zones) received compound identification cards that were distributed during the pre-
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intervention survey in 2012 [14]. PCD was carried out in government and mission health facili-
ties that covered intervention and control clusters. All facilities with a working laboratory and
full-time laboratory technician were eligible for inclusion, resulting in the inclusion of three
facilities in the PCD and exclusion of nine facilities without functioning laboratories. PCD took
place between 27 February and 3 September 2012 for a total of 27 wk [25] and relied on RDT-
based diagnosis to ensure comparable sensitivity and specificity of malaria diagnosis at the par-
ticipating facilities [26]. Any patient suspected of malaria who attended one of the three PCD
facilities was asked for their compound identification card and examined for fever and symp-
toms of malaria. If an individual was febrile (temperature> 37.5°C), an RDT was adminis-
tered. Clinic attendance, the number of clinical malaria cases (defined as fever in combination
with a positive RDT), and compound number information were recorded. Spot checks of PCD
facilities took place on a fortnightly basis to assess the completeness of records.
Entomological Surveys
Mosquito exposure was monitored in three intervention and three control clusters; in each of
the clusters, four compounds within hotspot boundaries and eight compounds located in the
evaluation zone were randomly selected for monitoring. Standard CDC light traps with a 6.3 V
incandescent light bulb (John W. Hock Company) were set indoors from 6 P.M. to 6 A.M. 1.5 m
above the ground at the foot end of occupied bednets [27]. Adult female anopheline densities
were recorded. Mosquito breeding site productivity was abandoned as a secondary outcome
because of the labor intensiveness of the larviciding performed by the same teams. Instead, the
presence or absence of anopheline larvae and pupae was determined in 15 permanent water
bodies in intervention hotspots, using 250-ml dippers and aiming for five and ten dips in water
bodies smaller than 5 m2 and larger than 5 m2, respectively.
Data Analysis
Statistical analyses were performed using Stata (v. 13, StataCorp). All analyses were based on
intention to treat, whereby all clusters were included in the analysis, regardless of the level of
coverage. The main outcome measure was nPCR parasite prevalence in the evaluation zone
surrounding hotspots. Each cluster was divided into two areas for the analysis: the hotspot and
the evaluation zone. To examine parasite prevalence in the evaluation zone as a function of dis-
tance from the hotspot boundary (secondary outcome), evaluation zones were stratified into
compounds located 1–249 m and 250–500 m from the hotspot boundary. For each survey,
comparisons between control and intervention clusters were made between hotspots as well as
each stratum of the evaluation zone. Each comparison was made using a t-test on the cluster-
level nPCR parasite prevalence. Measures of complexity of infection and prevalence were also
compared separately for each of the strata by a t-test of cluster-level means. Allelic richness, a
metric for allelic diversity [28], was calculated using the FSTAT software (v 2.9.3.2). Analyses
for nPCR parasite prevalence were carried out adjusting for baseline prevalence and known
malaria risk factors in the area: age group (5, 6–15, 16–25,>25 y), sex, altitude (<1,450,
1,450–1,500,>1,500 m), and living in a house with open eaves [15]. These covariates, which
were not part of the intervention, were defined a priori and were included simultaneously in a
single prespecified adjusted analysis. This was done by first performing an individual-level
logistic regression with only the factors we wished to adjust for as the predictors while exclud-
ing the intervention status of the cluster. This regression was then used to predict the preva-
lence in each cluster. We then calculated cluster-level residuals as the difference between the
observed and expected prevalence and compared the residuals of control and intervention clus-
ters using a t-test [29]. Since complexity of infection is count data with an extra-Poisson
Hotspot-Targeted Interventions and Malaria Transmission
PLOSMedicine | DOI:10.1371/journal.pmed.1001993 April 12, 2016 8 / 25
variation, negative binomial regression was used to estimate cluster-level means. To investigate
whether the intervention effect varied by distance from the hotspot, a linear regression model
of the cluster-level means was used. A model with distance from hotspot (categorized as 0 m,
1–249 m, and 250–500 m) and intervention but no interaction term for these factors was com-
pared to a model with an interaction between intervention and distance.
Data for this study were deposited in the Dryad Digital Repository [30].
Results
Detection of Malaria Hotspots
In the community survey conducted between 24 June and 31 July 2011, a total of 17,503 indi-
viduals were sampled, residing in 3,213 compounds across the 100-km2 study area (Fig 2A).
nPCR-detected parasite prevalence was 20.6% (2,663/12,912 observations from 2,802 com-
pounds) and was negatively associated with age (Table 1). The prevalence of antibodies to P.
falciparum AMA-1 or MSP-119 was 55.5% (9,092/16,381 observations from 3,099 compounds)
and was positively associated with age (p< 0.001; Table 1). Analysis of spatial clusters based
on combined antibody prevalence for AMA-1 and MSP-119 and age-adjusted antibody density
identified 27 statistically significant hotspots of variable size (0.035–4.5 km2; Fig 2B). These
hotspots covered 34.7% of the total field area and 44.4% (7,780/17,503) of all sampled individu-
als. From the identified 27 hotspots, we selected ten based on the inclusion criteria of the pres-
ence of an evaluation zone (1–500 m from the hotspot boundary) that was1 km away from
neighboring hotspots, as shown in Fig 2C. Malaria antibody prevalence for AMA-1 or MSP-119
was higher in nPCR parasite-positive compared to -negative individuals (odds ratio 1.94, 95%
CI 1.77–2.13, p< 0.001). Antibody prevalence and nPCR parasite prevalence showed similar
geographical patterns (Fig 2D), with nPCR parasite prevalence being highest in serologically
defined hotspots and declining with increasing distance from the hotspot boundary (Fig 3). In
all, 5.1% (126/2,493) of compounds with>3 inhabitants had nPCR parasite prevalence 80%;
67.5% (85/126) of these compounds were located inside serologically defined hotspots. Even at
an altitude> 1,500 m, where overall nPCR prevalence was 15.3% (646/4,212 individuals from
861 compounds), 3.8% (29/773) of compounds with>3 inhabitants had nPCR parasite
prevalence 80%, and 55.2% (16/29) of these compounds were located inside serologically
defined hotspots.
Intervention Coverage and Side Effects
In intervention hotspots, seven of the 432 compounds approached were either unoccupied at
the time of survey or declined participation and therefore did not participate in any of the
interventions (Fig 4). Larviciding of all water bodies continued for 16 wk after the start of the
intervention until the week after the final evaluation survey. LLIN distribution, IRS, and focal
MDA were implemented during a period of 3 wk, 22 March–15 April 2012. The percentage of
compounds that received PermaNet W 3.0 LLINs ranged from 94.5% (120/127) to 98.3% (58/
59) of compounds across intervention clusters, and between 89.2% (379/425) and 97.5% (154/
158) of sleeping spaces received IRS in the intervention clusters (Table 2). Of those compounds
that received IRS under the normal Kenyan national policy campaign (i.e., in control clusters),
62.8% (59/94) to 81.4% (79/97) of sleeping spaces were sprayed, as reported during the 8-wk
post-intervention survey (June–July 2012). In the intervention hotspots, 11.8% of compounds
(cluster range 9.0% [11/120] to 16.2% [7/42]) required more nets due to missing or damaged
LLINs, and there were no reported adverse effects associated with LLIN use. Ten individuals
(age range 2–62 y) residing in three compounds in the intervention hotspots reported adverse
effects to IRS. Reported symptoms included mild skin rashes and itching and one report of
Hotspot-Targeted Interventions and Malaria Transmission
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Fig 2. Spatial variation in malaria antibody prevalence and nPCR parasite prevalence in the study area in Rachuonyo South District during a
community survey conducted in June–July 2011. (A) Distribution of sampled compounds and variations in altitude across the study site (contour
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swollen and reddish mouth. All participants were provided treatment at Rachuonyo District
Hospital; these were the only identified safety issues associated with the interventions. Of all
compounds in the intervention hotspots, 94.0% (406/432 compounds) participated in screen-
ing of the sentinel population; on average 42.3% of the screened compounds (range 14.0% [8/
57 compounds] to 66.1% [72/109 compounds]) had1 RDT-positive member and were eligi-
ble for focal MDA. 94.9% (1,015/1,070) of inhabitants of these compounds completed treat-
ment, with loss to follow-up accounting for the majority of non-compliance. There were no
reports of side effects deemed likely to be related to treatment. Acceptability of interventions
was not formally assessed in interviews or questionnaires; all households in intervention clus-
ters were visited as part of the LLIN follow-up visits at 8-wk post-intervention to record any
side effects or complaints. The high coverage levels achieved indicate a high degree of approval
by the communities.
Effect of Hotspot-Targeted Interventions on nPCR Parasite Prevalence
in Evaluation Zones
Parasite prevalence in the malaria hotspots and in the evaluation zones surrounding the
malaria hotspots was determined based on nPCR parasite detection in three surveys conducted
in March–April (baseline), June–July (8 wk post-intervention), and August–September 2012
(16 wk post-intervention). Each survey took approximately 2 wk to complete. Mean baseline
nPCR parasite prevalence was 20.1% (range 8.4% [8/95] to 38.4% [73/190]) in the intervention
hotspots and 18.6% (range 6.7% [8/119] to 30.3% [37/122]) in the control hotspots (Table 3);
all compounds in the intervention clusters were sampled at baseline to facilitate evaluation of
the focal treatment campaigns, and all were included in the baseline survey [23]. At none of the
time points of evaluation did we observe a statistically significant reduction in nPCR parasite
prevalence in the evaluation zones surrounding targeted hotspots (Table 3; p 0.19). Hotspot-
specific data for nPCR prevalence for each survey are presented in S1 Fig and S1 Table.
Effect of Hotspot-Targeted Interventions on nPCR Parasite Prevalence
in Hotspots and Parasite Complexity of Infection
Secondary parasitological outcomes were nPCR parasite prevalence inside hotspots and nPCR
parasite prevalence in the evaluation zone as a function of distance from the hotspot boundary.
An exploratory parasitological endpoint was the complexity of malaria infections inside and
outside targeted hotspots. In the first post-intervention cross-sectional survey (at 8 wk), mean
interval = 25 m). (B) Combined seroprevalence (for AMA-1 or MSP-119) for individual 250 × 250 m sub-cells and the location of 27 significant hotspots derived
from spatial scan analysis of compound-level data. (C) The ten hotspots that were selected for the cluster-randomized trail, presented with evaluation zones.
(D) The 27 serological hotspot locations are overlaid on a map of nPCR-detected malaria parasite prevalence for compounds consisting of >3 individuals.
doi:10.1371/journal.pmed.1001993.g002
Table 1. Parasite prevalence and antibody prevalence in relation to age in the cross-sectional community survey in Rachuonyo South District in
June–July 2011 that was conducted for hotspot detection.
Age nPCR Parasite Prevalence, Percent (n/N) Antibody Prevalence, Percent (n/N)
5 y 21.2% (738/3,476) 33.8% (1,501/4,437)
6–10 y, 26.1% (609/2,337) 49.5% (1,483/2,994)
11–15 y, 24.8% (462/1,403) 65.1% (1,559/2,396)
16–25 y 19.2% (374/1,574) 69.5% (1,685/2,424)
>25 y 14.6% (480/3,286) 69.4% (2,864/4,130)
doi:10.1371/journal.pmed.1001993.t001
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nPCR parasite prevalence was 9.2% in intervention hotspots (cluster range 5.1% [7/138] to
13.5% [17/126]) compared to 19.4% in control hotspots (cluster range 9.6% [12/125] to 33.3%
[42/126]) (Table 3; p = 0.024 after adjustment for baseline prevalence and covariates). How-
ever, malaria transmission inside targeted hotspots was not completely interrupted. Although
not originally defined as a study endpoint, we determined parasite carriage in individuals who
were repeatedly sampled during the study period and were parasite-free by nPCR before the
intervention. Of 97 individuals who resided in intervention hotspots, were parasite negative
prior to the intervention, and were coincidentally sampled during the first evaluation survey,
four (4.1%) became parasite positive. These individuals (aged 4, 6, 10, and 34 y) did not report
spending any nights outside their compound between surveys. Sixteen weeks post-intervention,
at the end of the transmission season, there was no longer a statistically significant difference
in nPCR parasite prevalence between intervention and control hotspots (p = 0.27). We
observed no statistically significant trend in the effect of the intervention on nPCR parasite
prevalence in the evaluation zone in relation to distance from the hotspot boundary 8 wk post-
Fig 3. Malaria parasite prevalence by nPCR inside and outside serologically defined hotspots in the study area in Rachuonyo South District during
a community survey conducted in June–July 2011. nPCR-based parasite prevalence is plotted for individuals residing inside 27 serologically defined
hotspots (black bars), 1–249 meters from the hotspot boundary (grey hatched bars), 250–500 m from the hotspot boundary (open hatched bars), and >500
meters from the hotspot boundary (open bars). Parasite prevalence by nPCR is shown per altitude band. Error bars indicate the upper limit of the 95%
confidence interval; the p-value for the trend test is given, adjusting for correlations between observations from individuals living in the same compound. The
number of individuals for whom samples were available for nPCR inside hotspot boundaries was 2,222 individuals (1,350–1,449 m), 2,494 (1,450–1,499 m),
1,348 (1,500–1,549 m), and 118 (1,550–1,650 m). The number of individuals for 1–249 m from hotspot boundaries was 698 (1,350–1,449 m), 1,248 (1,450–
1,499 m), 1,113 (1,500–1,549 m), and 246 (1,550–1,650 m). The number of individuals for 250–500 m from hotspot boundaries was 544 (1,350–1,449 m),
681 (1,450–1,499 m), 661 (1,500–1,549 m), and 164 (1,550–1,650 m). The number of individuals for >500 m from hotspot boundaries was 544 (1,350–1,449
m), 176 (1,450–1,499 m), 405 (1,500–1,549 m), and 135 (1,550–1,650 m).
doi:10.1371/journal.pmed.1001993.g003
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Fig 4. Overview of the cluster-randomized trial conducted in Rachuonyo South District in March–September 2012.Clusters were serologically
defined hotspots with a surrounding 500-m evaluation zone and were randomly allocated to the intervention (n = 5) or control arm (n = 5). Cross-sectional
surveys were conducted at baseline (22 March–15 April 2012) and at 8 wk (16 June–6 July 2012) and 16 wk after the intervention (21 August–10 September
2012). In each survey, 25 compounds were randomly selected from within hotspots and 50 from the surrounding evaluation zone (25 compounds 1–249 m
from the hotspot boundary and 25 compounds 250–500 m from the hotspot boundary). In intervention hotspots, data were available for all compounds at
baseline and were therefore included in the analysis. If selected compounds were not inhabited or compoundmembers were absent, the nearest non-
selected inhabited compound was selected as a replacement. Compounds were not revisited before replacements were sought. fMDA, focal MDA.
doi:10.1371/journal.pmed.1001993.g004
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intervention (p = 0.27) or 16 wk post-intervention (p = 0.75). nPCR parasite prevalence was
not statistically significantly associated with reported travel in the preceding 3 mo in the survey
prior to the intervention (p = 0.30) or the surveys 8 wk (p = 0.24) and 16 wk (p = 0.58) after the
intervention. Only one nPCR-positive individual reported traveling to an area that is consid-
ered to experience higher malaria transmission. MSP-2 typing and fragment sizing was suc-
cessful in 97.2% (1,517/1,561) of nPCR-positive individuals coming from 421 compounds. We
observed no statistically significant reductions in allelic richness or in the number of detected
parasite clones inside malaria hotspots or in evaluation zones following the intervention
(Table 3). The average number of parasite clones, complexity of infection, and allelic richness
in the different surveys is presented by hotspot in S1 Table.
Effect of Hotspot-Targeted Interventions on Malaria Cases Reporting at
Health Facilities
The number of malaria cases reporting at health facilities coming from intervention and con-
trol clusters was defined as a secondary endpoint. During PCD there were 561 RDT-confirmed
clinical malaria cases in 1,175 febrile patients. The majority resided outside intervention or
control clusters. Twenty-two patients with RDT-confirmed clinical malaria could be located to
Fig 5. Indoor densities of female anophelines by light trap in intervention and control clusters in Rachuonyo South District in March–August 2012.
Each symbol represents the number of female anophelines caught indoors by CDC light trap inside hotspots (filled circles) and in evaluation zones (open
circles). Each trap night, four compounds were randomly selected within the hotspot and eight were selected in the evaluation zone per cluster. Findings are
summarized for trapping rounds prior to roll-out of interventions in 22 March–30 April 2012 (one trapping night per compound) and post-intervention in 1
May–30 June 2012 (three trapping nights per compound) and 1 July–31 August 2012 (five trapping nights per compound). Findings are presented for three
intervention clusters combined and for three control clusters combined.
doi:10.1371/journal.pmed.1001993.g005
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intervention clusters (incidence of 0.74 cases per 1,000 people per month based on an esti-
mated population size of 4,918) and 14 to control clusters (incidence of 0.64 cases per 1,000
people per month based on an estimated population size of 3,660).
Effect of Hotspot-Targeted Interventions on Number of Mosquitoes
Anophelesmosquito density and breeding site productivity were defined as secondary ento-
mological objectives. We sampled a total of 395 female anophelines during 648 trapping
nights. In the intervention clusters we caught an average of 1.14 female anophelines inside
hotspots and 0.47 in evaluation zones; in control clusters we caught an average of 0.90 female
anophelines inside hotspots and 0.50 in evaluation zones. We observed no apparent differ-
ence between intervention and control clusters (Fig 5) and considerable variation within and
between clusters (S2 Fig). Mosquito breeding site productivity was assessed in 15 sites per
intervention hotspot (n = 75 in total). Of the sites sampled prior to larviciding, 45% (34/75)
were positive, of which 12 had late-stage larvae and/or pupae. After larviciding, the number
of positive sites varied from 5.3% (4/75) to 28.0% (21/75), and no late-stage larvae or pupae
were detected.
Discussion
In this highland fringe setting in western Kenya, we identified numerous malaria hotspots with
serological and parasitological evidence of elevated levels of malaria transmission relative to
surrounding areas. Targeting these hotspots with a combination of four interventions, acting
against the human parasitemic reservoir and vector populations, had no measureable impact
on nPCR parasite prevalence in evaluation zones surrounding the hotspots and had only a
short-lived effect on nPCR parasite prevalence within hotspots.
Hotspot-targeted interventions have been hypothesized to form a highly efficacious
approach to reduce the burden of malaria in areas of heterogeneous malaria transmission
[9,12]. Operationally feasible approaches to detect stable hotspots form a prerequisite for tar-
geted interventions. Our detailed community survey, conducted in preparation for the inter-
vention, revealed a large number of serologically defined hotspots of malaria transmission.
These serological hotspots, indicative of longer-term exposure [17], showed a strong associa-
tion with current parasite carriage at both the individual and geographical level: malaria-anti-
body-positive individuals were significantly more likely to be parasite positive, and nPCR
parasite prevalence decreased with distance from the center of serologically defined hotspots.
This suggests temporal stability of spatially heterogeneous transmission [6,9] and the suitability
of targeting interventions at a fine spatial scale. We selected ten hotspots for a cluster-random-
ized trial on the impact of hotspot-targeted interventions with IRS, LLINs, weekly larviciding
[31], and focal MDA to minimize the parasite reservoir in humans at the start of the transmis-
sion season. Despite achieving high coverage with all interventions, we observed no measurable
impact on our primary endpoint, the proportion of nPCR parasite-positive individuals in the
evaluation zone surrounding targeted hotspots. nPCR parasite prevalence was only transiently
reduced inside targeted hotspots, and there was no impact on the complexity of malaria infec-
tions inside or outside hotspots. Whilst heterogeneous malaria transmission may influence the
acquisition of malaria immunity and clinical manifestations [6,32], we hypothesized that our
intervention would reduce not only the prevalence of asymptomatic infections but also the
incidence of clinical malaria episodes in intervention compared to control clusters. PCD at
health facilities identified 36 RDT-confirmed clinical malaria episodes in individuals who
resided in intervention or control clusters, and no evidence that the intervention reduced the
clinical burden of malaria. Our decision to monitor the incidence of malaria cases passively
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was based on the low efficiency of active monitoring of infections in low endemic settings [33],
although we acknowledge that PCD leads to a considerable loss in power compared to active
case detection [34]. As a consequence, our approach will have resulted in an unknown number
of malaria episodes that were missed due to health care seeking behavior or other factors
[34,35]. It is also conceivable that we missed further malaria cases because health facility
attendees failed to present with compound identification cards, although we would expect this
bias to be non-differential between the control and intervention arms. These are shortcomings
of our PCD system. As a result, we cannot exclude an impact of our interventions on the inci-
dence of clinical malaria episodes but can conclude that parasitologically confirmed clinical
malaria episodes were passively reported from both intervention and control clusters at a simi-
lar rate.
Our intervention failed to sustainably reduce malaria transmission inside targeted hotspots.
Approximately 4% of individuals in intervention hotspots became parasite positive within 8 wk
of the intervention. This infection incidence is remarkable considering the low level of trans-
mission intensity in the area; the baseline nPCR parasite prevalence of 18.6%–23.5% translates
to an estimated microscopy parasite prevalence of 5.7%–7.9% [36] and indicates hypoendemic
transmission [37]. There are several possible reasons for the apparent failure to completely
eliminate malaria transmission inside hotspots and the undetectable impact in the evaluation
zones surrounding targeted hotspots. First, it is possible that our interventions did not clear
vector populations or prevent human–vector contact inside hotspots to the extent that is
required to interrupt local transmission. Insecticide resistance is a key consideration for any
vector-based malaria intervention. Resistance to deltamethrin and permethrin has been
detected in the study area for A. gambiae s.l. and A. funestus [38,39] but has not reached satura-
tion, as observed in other African settings [40,41], and there is currently no evidence that insec-
ticide resistance affects control efforts in the region [40–42]. We purposefully selected
interventions that have potency in areas of insecticide resistance: LLINs that include piperonyl
butoxide as a syngergist to enhance the efficacy of deltamethrin in resistant vectors [43] and
larviciding with B. thuringiensis var. israelensis, to which there is no reported vector resistance
in the region [22] and which is effective against both indoor- and outdoor-feeding mosquitoes.
Activity against outdoor-feeding mosquitoes is of relevance because of increased outdoor biting
rates following the scaling up of IRS and LLIN coverage [44,45] and the presence of a previ-
ously unidentified malaria vector in the study area that exhibits a preference for outdoor biting
[16]. Despite our intensive vector control efforts, we detected ongoing breeding site productiv-
ity and mosquito exposure in targeted hotspots. Second, there may have been residual trans-
mission from parasite carriers who were unidentified and untargeted by our treatment
campaign. Undetected low-density parasite carriage may have been responsible for sustained
transmission following recent mass screening and treatment campaigns in Zanzibar [46]. We
estimate that our approach identified approximately 77% of all nPCR-positive individuals in
the area [23]. It is currently unknown whether the untargeted fraction of infections, which are
mostly of low parasite density, is sufficient to sustain transmission; however, infectiousness
from low-density infections has been demonstrated [47]. A third potential explanation for the
apparent failure to completely eliminate malaria transmission is the importation of parasites
by individuals traveling to areas of higher endemicity such as the nearby Asembo Bay area
[48]. We failed to detect an association between reported travel and nPCR parasite prevalence
during any of the surveys. Analysis of data from earlier surveys in this area indicates that most
trips that involve an overnight stay occur within families or represent travel to urban areas
where malaria risk is low [49]. In our surveys, only one nPCR-positive individual reported trav-
eling to an area of known intense malaria transmission. A fourth possible explanation is the
influx of infected mosquitoes from untargeted hotspots. We selected hotspots and evaluation
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zones for the intervention trial that were in relative isolation from neighboring hotspots,
assuming that vector dispersion in a densely populated area would primarily occur over<1 km
distances [50]. Importation of infected mosquitoes into the intervention hotspots is possible,
most likely from areas that surrounded hotspots but were themselves not detected as transmis-
sion hotspots. The points above may all contribute to varying degrees and combine for the fifth
possible explanation, which is that our hypothesis of how hotspots seed malaria transmission
does not apply to the transmission dynamics in our study setting. Understanding host and
mosquito movement in relation to fine-scale patterns of mixing parasite populations is of key
importance for rationally deploying targeted interventions [51]. Our findings suggest that
transmission may not primarily occur from hotspots to the surrounding areas. Our hotspot
definition encapsulated 34.7% of the total area and 44.4% of all inhabitants, but 32.5% (41/126)
of all compounds with80% nPCR parasite prevalence were located outside statistically signif-
icant malaria hotspots. These high parasite prevalence compounds may have fueled transmis-
sion outside and into our serologically defined hotspots. The existence of isolated high parasite
prevalence compounds has been described before [12,23] and suggests that our hypoendemic
study area has not yet reached the phase where parasite carriage is confined to malaria hotspots
or primarily occurs from hotspots to surrounding areas.
There are several limitations to this study. Our study was conducted in the presence of other
ongoing interventions that may have made it difficult to attribute any specific, small changes in
nPCR parasite prevalence to our intervention. The absence of detailed concurrent meteorologi-
cal data makes it impossible to assess the impact of our interventions in terms of the exact tim-
ing of the local changes in rainfall and temperature that determine malaria transmission
dynamics. Our trial included a total of ten clusters during a single season and was therefore not
powered to detect subtle effects of hotspot-targeted interventions nor designed to detect effects
of interventions that become apparent over multiple transmission seasons. Furthermore, we
saw a higher than expected level of inter-cluster variation. Sample size calculations were based
on an assumed coefficient of variation of 0.4. In fact, the baseline data indicate a coefficient of
variation of 0.5, which would have also reduced the power of the trial to detect subtle effects of
hotspot-targeted interventions. The limited number of clusters is a major limitation of the cur-
rent study. Our sample size of five intervention and five control clusters was based on the
assumption that our combination of four malaria interventions would (temporarily) eliminate
malaria transmission inside targeted hotspots [9] and would result in near elimination of
malaria from the surrounding community. Neither hypothesis was confirmed. It is unclear to
what extent the results from our trial can be extrapolated to other settings. Our study was con-
ducted in a highland fringe setting with low and heterogeneous malaria transmission. Whilst
this setting is markedly different from nearby lowland areas of intense malaria transmission,
we believe our study setting is representative of many other East African settings with continu-
ous habitation and low-intensity malaria transmission that is spatially heterogeneous as a con-
sequence of large- and small-scale determinants of malaria transmission [9,12]. Our
observation that individual compounds with high levels of asymptomatic parasite carriage exist
within areas where parasite carriage is generally much lower has also been reported in coastal
Kenya [12]. We consider the existence of such single-compound hotspots an important hurdle
for hotspot-targeted interventions since these compounds are logistically very challenging to
identify and may require very intensive community surveys. In coastal Kenya, hotspots that are
unstable in space and time [6] may further affect the operational attractiveness of hotspot-tar-
geted interventions.
Hotspot-Targeted Interventions and Malaria Transmission
PLOSMedicine | DOI:10.1371/journal.pmed.1001993 April 12, 2016 19 / 25
Conclusion
Approximately one-third of our study area fell within identified hotspots of malaria transmis-
sion. Hotspot targeting of interventions failed to influence malaria transmission dynamics out-
side the targeted area and resulted in a modest and transient reduction in nPCR parasite
prevalence inside targeted hotspots. Whilst our study may have been underpowered to detect
subtle effects on malaria transmission, we consider it unlikely that hotspot-targeted interven-
tions are cost-effective in our setting. The considerable resources required for hotspot detection
at the local scale are unlikely to be offset by savings from a more rational deployment of inter-
ventions in the study area. As a result, areas like our study site in Rachuonyo South District,
with highly heterogeneous but widespread malaria transmission, may currently benefit most
from an untargeted community-wide approach that reaches all malaria-infected and malaria-
exposed individuals. The hotspot-targeted approach may have validity and should be tested
further in settings where human settlement is more nuclear.
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Editors' Summary
Background
In 2015, there were about 200 million cases of malaria (a mosquito-borne parasitic disease)
worldwide and about 438,000 malaria-related deaths. Most of these deaths were caused by
Plasmodium falciparum, which is transmitted to people by night-flying Anophelesmosqui-
toes. When infected mosquitoes bite people, they inject “sporozoites,” a parasitic form that
replicates in the liver. After a few days, the liver releases “merozoites,” which invade red
blood cells, where they replicate before bursting out and infecting more red blood cells. This
increase in parasitic burden causes recurring flu-like symptoms and can cause organ damage
and death if not treated promptly with antimalarial drugs. Infected red blood cells also
release “gametocytes,” which infect mosquitoes when they take a blood meal. In the mos-
quito, gametocytes multiply and develop into sporozoites, which completes the parasite’s life
cycle. Malaria can be prevented by controlling Anophelesmosquitoes and by avoiding mos-
quito bites. Methods for controlling mosquitoes include treating stagnant water with “larvi-
cides” to kill immature mosquitoes and spraying houses with insecticides (indoor residual
spraying); sleeping under insecticide-treated bednets is an effective way to avoid mosquito
bites. Treatment with antimalarial drugs also decreases malaria transmission.
WhyWas This Study Done?
Improved malaria prevention has reduced malaria-related deaths over recent years, and
experts are now trying to devise strategies to eradicate malaria. Targeting malaria trans-
mission hotspots—regions where the intensity of transmission is higher than in surround-
ing areas—is one potential strategy for reducing malaria transmission. Mosquito densities
are highest in hotspots, and people living in hotspots may transmit malaria parasites to a
large number of mosquitoes that can then spread malaria transmission to wider areas. Tar-
geting malaria hotspots might, therefore, benefit communities in both the targeted region
and the surrounding area. Here, the researchers look for malaria hotspots in Rachuonyo
South District in the western Kenyan highlands, an area where malaria transmission inten-
sity is generally low, and undertake a cluster-randomized controlled trial to determine the
impact of hotspot-targeted malaria control interventions on malaria transmission inside
hotspots and in surrounding communities. A cluster-randomized trial compares outcomes
in groups (clusters) of people (here, people living in different malaria hotspots) randomly
assigned to receive different interventions.
What Did the Researchers Do and Find?
Using survey results and spatial scanning techniques, the researchers detected 27 serologi-
cally defined malaria hotpots (clusters of people with antibodies to the malaria parasite) in
Rachuonyo South District. Of these, ten hotspots were at least 1.5 kilometers from the
nearest neighboring hotspot (allowing space for evaluation zones and a buffer between
hotspots). During the following peak malaria transmission period, they randomly allo-
cated five of these hotspots to targeted interventions (larvicide treatment of stagnant
water, community distribution of insecticide-treated bednets, indoor residual spraying,
and mass drug administration) and five hotspots to the control intervention (the Kenyan
national policy of annual indoor residual spraying, routine case management at clinics,
and bednet distribution at antenatal clinics). Intervention coverage exceeded 87% for all
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the components of the targeted intervention. However, the intervention did not change
the prevalence of parasites (the proportion of the population carrying parasites) at 8 or 16
weeks post-intervention in the evaluation zones—the areas 1–500 meters from the border
of the hotspots (the study’s primary outcome). There was a statistically significant reduc-
tion in parasite prevalence inside intervention hotspots at 8 but not 16 weeks post-inter-
vention (a statistically significant change is one unlikely to have happened by chance).
Finally, similar numbers of individuals from the intervention and control clusters attended
local health facilities and were found to have confirmed clinical malaria, and there was no
significant difference between intervention and control clusters in the number of mosqui-
toes caught within hotspots or evaluation zones.
What Do These Findings Mean?
These findings show that, despite high coverage, the impact of interventions targeting
malaria hotspots in Rachuonyo South District on parasite prevalence was modest, tran-
sient, and restricted to the targeted hotspot. It may be that the number of clusters included
in this study was too small to detect any subtle effects of hotspot-targeted interventions.
Moreover, the effect of the targeted interventions may have been masked by other ongoing
interventions in the region. However, these findings suggest that malaria transmission in
Rachuonyo South District may not occur primarily from hotspots to the surrounding
areas. Thus, areas where malaria transmission is widespread but includes hotspots might
benefit most from an untargeted community-wide approach to malaria prevention.
Additional Information
This list of resources contains links that can be accessed when viewing the PDF on a device
or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001993.
• Information is available from the World Health Organization on malaria (in several lan-
guages); its Global Technical Strategy for Malaria 2016–2030 provides a framework to
guide countries towards malaria elimination; theWorld Malaria Report 2015 describes
the current global malaria situation and includes information on malaria in individual
African countries and recommended policies and strategies for malaria control
• The US Centers for Disease Control and Prevention provides information on malaria
(in English and Spanish), including information about malaria prevention and personal
stories about malaria
• The UK National Health Service Choices website also provides information about
malaria, including a personal story
• Information is available from the Roll Back Malaria Partnership on the global control of
malaria (in English and French)
• MedlinePlus provides links to additional information on malaria (in English and
Spanish)
• More information about this trial is available
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